References
Phillipson EA (1993) Sleep apnea—a major public health problem. N Engl J Med 29:328(17):1271–1273
Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, Leung RS, Bradley TD (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19(12):2271–2277
Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure; types and their prevalences, consequences, and presentations. Circulation 97:2154–2159
Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, Shamsuzzaman AS, Somers VK (2003) Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107:2589–2594
Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, Malouf JF, Ammash NM, Friedman PA, Somers VK (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110:364–367
Sjostrom C, Lindberg E, Elmasry A, Hagg A, Svardsudd K, Janson C (2002) Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax 57:602–607
Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B (1999) Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 92:79–84
Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68–73
Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S, Bradley TD (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348:1233–1241
Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T (2005) Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165:447–452
Stradling JR (2004) Reducing the cost of treating obstructive sleep apnea. Am J Res Crit Care Med 170:1143–1144
Teschler Berthon-Jones (1998) Intelligent CPAP systems: clinical experience. Thorax 53(Suppl 3):S49–S54
Condos R, Norman RG, Krishnasamy I, Peduzzi N, Goldring RM, Rapoport DM (1994) Flow limitation as a noninvasive assessment of residual upper-airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea. Am J Res Crit Care Med 150(2):475–480
Massie CA, McArdle N, Hart RW, Schmidt-Nowara WW, Lankford A, Hudgel DW, Gordon N, Douglas NJ (2003) Comparison between automatic and fixed positive airway pressure therapy in the home. Am J Respir Crit Care Med 167:20–23
Masa JF, Jimenez A, Duran J, Capote F, Monasterio C, Mayos M, Teran J, Hernandez L, Barbe F, Maimo A, Rubio M, Montserrat JM (2004) Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med 170:1218-1224
Sin DD, Mayers I, Man G, Pawluk L (2002) Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea. Chest 121:430–435
Krieger J (1992) Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snores. Sleep 15:S42–S46
Chervin RD, Theut S, Bassetti C, Aldrich MS (1997) Compliance with nasal CPAP can be improved by simple interventions. Sleep 20(4):284–289
Lewis KE, Seale L Bartle IE, Watkins AJ, Ebden P (2004) Early predicators of CPAP use for the treatment of obstructive sleep apnea. Sleep 27(1):134–138
Kribbs NB et al (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147:887–895
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farrell, P.C. The future of sleep medicine and the business of sleep. Sleep Breath 10, 111–114 (2006). https://doi.org/10.1007/s11325-006-0066-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-006-0066-x